Assessment of NSAID-treated Patients Adherence to Co-prescribed Proton Pump Inhibitor (PPI)
NCT ID: NCT01519375
Last Updated: 2012-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
102 participants
OBSERVATIONAL
2012-03-31
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adherence to Gastro-protection in Non-steroidal Anti-inflammatory Drug (NSAID) Using Patients
NCT00699725
Strategies for Improving Proton Pump Inhibitors (PPIs) Prescription Associated to Non-steroidal Anti-inflammatory Drugs (NSAIDs)
NCT01128127
Cardio-cerebrovascular Disease and Aspirin Ulcer Relapse Evaluation
NCT01051388
Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer
NCT00595517
Evaluation of the Effect of the Association of Proton Pump Inhibitor (PPIs) With Non-Steriodal Anti-Inflamatories (NSAIDs) in Work Leave Time.
NCT00717119
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Patients with Osteoarthritis, Rheumatoid Arthritis and Ankylosing Spondylitis, 18 years or older
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Prescription of oral NSAID treatment for OA, RA or AS, where low dose is not sufficient
* Prescription of PPI for prevention of NSAID associated GI ulcers, with instruction to take PPI same day as when taking NSAID.
Exclusion Criteria
* Patients prescribed PPI as acute treatment of GI events or symptoms within 8 weeks
* Inability to complete PROs
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Georgios Stratelis, MD, PhD
Role: STUDY_DIRECTOR
AstraZeneca Nordics, B674:4 151 87 Södertälje, Sweden
Kenneth Henriksson, MD
Role: PRINCIPAL_INVESTIGATOR
Reuma City, 111 52 Stockholm, Sweden
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Kristianstad, , Sweden
Research Site
Kristinehamn, , Sweden
Research Site
Limhamn, , Sweden
Research Site
Partille, , Sweden
Research Site
Skanör, , Sweden
Research Site
Stockholm, , Sweden
Research Site
Ullanger, , Sweden
Research Site
Vännäs, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-RSE-ATC-2011/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.